Fisher & Paykel Healthcare, a New Zealand-based medical device company, began as part of the Fisher & Paykel appliance manufacturer in 1934 and evolved into a global leader in respiratory humidification and obstructive sleep apnea treatment. The company was demerged and listed on the NZX in 2001, and has since grown through innovation, international expansion, and strategic acquisitions.
Maurice Paykel and Woolf Fisher establish Fisher & Paykel as an appliance importer and manufacturer in Auckland, New Zealand, initially focusing on washing machines and refrigerators. #corporate #history
Fisher & Paykel begins research into respiratory humidification, leveraging its engineering expertise to develop heated humidifiers for hospital use. #medicaldevices #innovation
The company introduces its first heated humidifier for respiratory therapy, improving patient comfort and safety in hospital settings. #respiratory #innovation
Fisher & Paykel develops the Optiflow nasal high-flow therapy system, providing non-invasive respiratory support for neonates and adults. #medicaldevices #respiratory
The company begins developing CPAP masks and humidifiers for obstructive sleep apnea, entering the growing home healthcare market. #sleepapnea #medicaldevices
The HC200 heated humidifier becomes a standard in hospital ventilators, solidifying Fisher & Paykel's reputation in respiratory care. #respiratory #innovation
Fisher & Paykel Healthcare opens a subsidiary in California to expand its presence in the North American market, a key strategic move. #expansion #global
Fisher & Paykel Healthcare is demerged from Fisher & Paykel Appliances and listed on the New Zealand Exchange (NZX), raising capital for growth. #ipo #corporate
Introduction of the Icon CPAP mask series, offering improved comfort and seal for sleep apnea patients. #sleepapnea #productlaunch
Fisher & Paykel Healthcare establishes a European headquarters in the Netherlands to serve growing demand in the region. #expansion #global
Fisher & Paykel acquires the heated humidifier product line from ResMed, strengthening its position in respiratory humidification. #acquisition #corporate
The Optiflow Junior system is introduced specifically for pediatric patients, expanding the company's neonatal and pediatric respiratory offerings. #respiratory #pediatrics
Michael Daniell becomes Chief Executive Officer, leading the company through a period of rapid international growth and innovation. #leadership #corporate
Fisher & Paykel Healthcare achieves annual revenue exceeding NZD 1 billion for the first time, driven by strong demand for respiratory products. #financial #milestone
Introduction of the Airvo 2, an advanced nasal high-flow therapy platform that becomes a standard in respiratory care worldwide. #innovation #respiratory
Fisher & Paykel Healthcare opens a sales office in Shanghai, China, tapping into the rapidly growing Asian healthcare market. #expansion #asia
The Simplus mask is introduced, featuring a unique dual-layer cushion for improved seal and comfort, quickly becoming a top seller. #sleepapnea #productlaunch
Fisher & Paykel acquires ARC Medical, a UK-based respiratory device company, to strengthen its European market position. #acquisition #corporate
During the H1N1 pandemic, Optiflow nasal high-flow therapy gains prominence for treating respiratory failure, boosting the company's profile. #respiratory #pandemic
The MR850 heated humidifier is introduced, offering advanced temperature and humidity control for invasive and non-invasive ventilation. #innovation #respiratory
Fisher & Paykel acquires SleepNet, a US-based CPAP mask manufacturer, expanding its sleep apnea product portfolio. #acquisition #sleepapnea
The Optiflow 850 integrated system combines the MR850 humidifier with nasal cannula, simplifying high-flow therapy in hospitals. #respiratory #innovation
Lewis Gradon succeeds Michael Daniell as CEO, continuing the company's focus on innovation and global expansion. #leadership #corporate
The Evora mask is launched, featuring a unique 'cushion under nose' design that reduces pressure on the forehead and improves comfort. #sleepapnea #productlaunch
Global demand for Fisher & Paykel's respiratory devices, particularly Optiflow, skyrockets during the COVID-19 pandemic, leading to production expansion. #pandemic #respiratory
Fisher & Paykel opens a new manufacturing plant in Auckland to meet surging global demand for respiratory products during COVID-19. #manufacturing #expansion
Fisher & Paykel Healthcare's market cap peaks at over NZD 20 billion, making it one of the most valuable companies on the NZX. #financial #milestone
The SleepStyle CPAP device is introduced, featuring integrated humidification and smart algorithms for personalized therapy. #sleepapnea #innovation
Fisher & Paykel acquires AireHealth, a US digital health company specializing in remote monitoring for respiratory patients. #acquisition #digitalhealth
Fisher & Paykel Healthcare reports annual revenue of NZD 5.8 billion, driven by continued demand for respiratory and sleep apnea products. #financial #milestone
Introduction of the Ora airway, an oral device for sleep apnea that provides an alternative to CPAP masks. #sleepapnea #productlaunch
Fisher & Paykel announces a partnership with AI startup to develop machine learning algorithms for early detection of respiratory deterioration. #innovation #ai
Lewis Gradon retires, and Dr. Helen Robinson is appointed as CEO, becoming the first woman to lead the company. #leadership #diversity
A new office and manufacturing facility in Bangalore, India, is opened to serve the growing healthcare market in South Asia. #expansion #asia
A new Optiflow system with integrated pulse oximetry and AI-driven flow adjustment is launched, further advancing high-flow therapy. #innovation #respiratory
Fisher & Paykel Healthcare announces it has achieved carbon neutrality in its operations, in line with its sustainability commitments. #sustainability #corporate
A compact, home-based diagnostic tool for sleep apnea is launched, enabling remote screening and reducing hospital visits. #sleepapnea #digitalhealth
Fisher & Paykel partners with the World Health Organization to distribute respiratory devices to low-income countries, enhancing global health equity. #globalhealth #partnership
Fisher & Paykel Healthcare marks 100 years since the founding of the original company, celebrating its evolution into a global medtech leader. #corporate #milestone
A wearable device for continuous respiratory monitoring is introduced, using non-invasive sensors and cloud connectivity. #innovation #wearable